Vascular Research Initiatives Conference (VRIC) 2022
CME Claiming Update
If you earned CME for this course, SVS has already transferred credit on your behalf. Please login to your ABS portal to confirm your credits are listed. If earned credits are missing, please contact education@vascularsociety.org no later than April 1, 2023, so we have time to resolve any issue before the cut-off date of June 30, 2023.
The Vascular Research Initiatives Conference (VRIC) emphasizes the exchange of basic and translational vascular science that stimulates thoughtful discussion and motivates participants to discover solutions to important problems affecting vascular patients. The VRIC brings together vascular surgeons, vascular biologists, physicians with an interest in vascular problems, vascular surgery trainees and research trainees in vascular surgery and vascular biology.
VRIC 2022, with the theme "Translational Immunology and Cardiovascular Disease," will take place the day before the American Heart Association's Vascular Discovery 2022 Conference in Seattle, Washington (May 12-14).
Registration for this event is now closed.
Agenda
Access the full conference agenda here.
Accreditation Information
Date: May 11, 2022
Last Day to Claim CME: June 30, 2022
Max AMA PRA Category 1 Credits ™: 5.50
By participating in this CME activity, the learner will be able to:
- Enhance research techniques and clinical trials.
- Utilize a multidisciplinary approach to patient management based on clinical studies & guidelines.
- Apply current standards of care in the management of vascular patients.
This CE Activity is supported through an educational grant provided by Gore and Boston Scientific.
Accreditation Statement
The Society for Vascular Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Society for Vascular Surgery designates this live course for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
The ACCME requires that the SVS, as an accredited provider of CME, disclose the relevant financial relationships of the planners, faculty, and any other individuals in a position to control content of this activity. If there is a relevant financial relationship that has been disclosed, please find it below:
| Name of Individual | Company/Organization | Nature of Financial Relationship(s) |
| Mohamed Zayed, MD, PhD, FACS |
|
|
| Jean Marie Ruddy, MD FACS |
|
|
| Caitlin W. Hicks MD, MS |
|
|
| Andrea Obi, MD |
|
|
| Iraklis I. Pipinos, MD |
|
|
| Elsie Ross, MD |
|
|
| Jason MacTaggart, MD |
|
|
| Nicholas Osborne, MD |
|
|
| George J Arnaoutakis |
|
|
| Michael S Conte, MD |
|
|
| Scott M. Damrauer, MD |
|
|
| Michael Holinstat |
|
|
| Hanjoong Jo, PhD |
|
|
| Katalin Kauser MD PhD DSc |
|
|
| Jason S. Knight, MD, PhD |
|
|
| Nicholas J. Leeper |
|
|
| Kaspars Maleckis, Ph.D. |
|
|
| Sara A. Myers, PhD |
|
|
| Clay F Semenkovich M |
|
|
| Qizhi Tang, PhD |
|
|
| Shant M. Vartanian, MD |
|
|
| Kerstin Rebrin, MD, PhD |
|
|
| Peter A. Schneider, MD |
|
|
All other individuals in control of content have indicated that there are no relevant financial relationships with ineligible companies to be disclosed. All relevant financial relationships have been mitigated.
Additional Information About VRIC
New and evolving topics may be discussed, debated, and explored during the VRIC. Planners and faculty must facilitate engagement with these topics without advocating for or promoting practices that are not or not yet adequately based on current science, evidence, and clinical reasoning.
As a condition of its ACCME Accreditation, SVS’s CE activities will not advocate for unscientific approaches to diagnosis or therapy, or promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
VRIC 2022 Premier Speakers
| Lecture | Speaker | Talk Title |
|
Alexander W. Clowes Distinguished Lecture The lecture is named for the late SVS member Alec Clowes, a renowned mentor and surgeon-scientist who demonstrated an exceptional commitment to research in vascular disease and played a critical role in VRIC. |
Kathleen Martin, PhD | Epigenetic Regulation of Vascular Smooth Muscle Plasticity |
|
Translational Panel |
Katey Rayner, PhD, FAHA | Cholesterol, Inflammation and Atherosclerosis: Expecting the Unexpected |
| Translational Panel | Nicholas Leeper, MD | Bench-to-bedside translation of pro-efferocytic therapies |
Health & Safety Protocols
We are delighted to welcome our VRIC attendees, staff and guests to Seattle for VRIC 2022. The health and safety of our members and guests are of primary importance. We have been monitoring the current situation with COVID-19, and are taking measures to support compliance with Center for Disease Control and King County guidelines.
At a minimum, you can expect the following health and safety protocols to be in place:
Proof of Vaccination/Negative COVID test (within 72 hours of travel). All attendees and staff will be required to provide proof of vaccination OR negative COVID test taken within 72 hours of arrival date in Seattle. All individuals will need to present documentation at the on-site registration, just outside the session room, prior to being issued an official meeting badge.
Masks: Masks will be optional for this event.
More Information:
SVS will communicate any changes to this information as it becomes available. Looking forward to seeing everyone in Seattle!
COVID-19 Waiver
All registrants must complete an online COVID-19 release and waiver as part of registration. To review the waiver ahead of time, please click here.
Attendee Housing
Attendees can now make reservations at the Sheraton Grand Seattle Hotel for VRIC 2022 either online or by phone.
Online reservations will be made through the Vascular Discovery Conference hotel portal. Please note:
- If booking by phone, you must mention you are booking as part of the AHA’s Vascular Discovery room block to get the discounted rate of $199/night + taxes/fees.
SHERATON GRAND SEATTLE HOTEL
1400 6th Avenue
Seattle, Washington 98101
Main Hotel Phone: +1 206-621-9000
Toll-Free Reservations: +1 888-627-7056
The rate is available on a first-come, first-served basis. After April 18 reservations will be accepted at the group rate, if rooms are still available. The group rate will be honored 3 days before and after the Vascular Discover meeting (May 12-14).